Insider selling at this scale is notable but not alarming for a $189M biotech. Watch for any upcoming corporate events (e.g., clinical data, partnership announcements) that may have motivated the trades. The lack of 10b5-1 plan disclosure reduces the signal's reliability.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 6 $4.60entry
- T+1 · 4mo ago −0.65%α −1.52% · $4.57
- T+5 · 4mo ago −9.13%α −10.06% · $4.18
- T+20 · 4mo ago −10.43%α −10.02% · $4.12
- T+60 · 7w ago +3.26%α −0.31% · $4.75
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
COO/CBO Joshua Hexter and CFO Avraham Gabay collectively sold $942K in open-market shares on July 1, 2026, representing ~0.5% of Oramed's $189M market cap. The sales are moderate in size and involve two senior officers, but insider selling is a weak directional signal per academic literature, especially without evidence of 10b5-1 plans or a clear blackout context.
Key Financial Metrics
Key Facts
- Two C-suite insiders (COO/CBO and CFO) sold shares on July 1, 2026
- Total open-market sales: $942,000 at ~$4.46-$4.51 per share
- Sales represent ~0.5% of Oramed's $189M market cap
- Hexter also exercised derivatives on July 2 (non-cash events)
- Analyst consensus is bearish: 0% bullish, mostly hold/sell/strong sell ratings
Financial Impact
$942K in insider selling, about 0.5% of market cap
Risk Factors
- Additional insider selling could pressure shares
- Bearish analyst consensus may amplify negative sentiment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORMP-1783026099934 |
Track record
4 reports on ORMP
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $4.03 Now $3.90 −3.23% settles Dec 15
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $4.55 to $4.11 Now $3.90 −14.29% ▼ −9.67% −7.20% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 4/10 Viewing Entry $4.60 to $4.12 Now $3.90 −15.22% ▼ −10.43% −10.02% vs SPY
- Jun 30, 202619w ago 8-K Mixed 5/10 Entry $4.61 to $3.97 Now $3.90 −15.40% ▼ −13.88% −11.70% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers